Eric Coldwell
Stock Analyst at Baird
(3.70)
# 788
Out of 4,944 analysts
200
Total ratings
58.56%
Success rate
3.71%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Outperform | $197 → $203 | $148.12 | +37.05% | 13 | Aug 13, 2025 | |
| OMI Owens & Minor | Maintains: Outperform | $10 → $7 | $5.33 | +31.33% | 19 | Aug 12, 2025 | |
| FTRE Fortrea Holdings | Upgrades: Outperform | $7 → $9 | $7.84 | +14.80% | 8 | Aug 4, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $290 → $302 | $272.54 | +10.81% | 14 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Outperform | $150 → $224 | $176.29 | +27.06% | 21 | Jul 24, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $313 → $490 | $468.00 | +4.70% | 19 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $159 → $196 | $190.23 | +3.03% | 18 | Jul 23, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $22 | $24.53 | -10.30% | 8 | May 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $155.00 | -9.68% | 14 | May 8, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $179.04 | +8.36% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $16 | $9.73 | +64.44% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $663.17 | +3.74% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.89 | +328.93% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $60.46 | -25.57% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $65.90 | +0.15% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.64 | +2,704.88% | 4 | Nov 10, 2017 |
Cardinal Health
Aug 13, 2025
Maintains: Outperform
Price Target: $197 → $203
Current: $148.12
Upside: +37.05%
Owens & Minor
Aug 12, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $5.33
Upside: +31.33%
Fortrea Holdings
Aug 4, 2025
Upgrades: Outperform
Price Target: $7 → $9
Current: $7.84
Upside: +14.80%
Labcorp Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $290 → $302
Current: $272.54
Upside: +10.81%
ICON Public Limited Company
Jul 24, 2025
Upgrades: Outperform
Price Target: $150 → $224
Current: $176.29
Upside: +27.06%
Medpace Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $313 → $490
Current: $468.00
Upside: +4.70%
IQVIA Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $159 → $196
Current: $190.23
Upside: +3.03%
Premier
May 15, 2025
Maintains: Neutral
Price Target: $19 → $22
Current: $24.53
Upside: -10.30%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $155.00
Upside: -9.68%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $179.04
Upside: +8.36%
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.73
Upside: +64.44%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $663.17
Upside: +3.74%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.89
Upside: +328.93%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $60.46
Upside: -25.57%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $65.90
Upside: +0.15%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.64
Upside: +2,704.88%